We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$15.7B
AUM Growth
+$1.09B
Cap. Flow
-$161M
Cap. Flow %
-1.02%
Top 10 Hldgs %
41.17%
Holding
59
New
9
Increased
17
Reduced
27
Closed
1
Avg Time Held Equity + Options
8.4 quarters
Top 10 Avg Time Held Equity + Options
4.2 quarters
Top 20 Avg Time Held Equity + Options
7.4 quarters
Avg Time Held Equity only
8.6 quarters
Top 10 Avg Time Held Equity only
4.2 quarters
Top 20 Avg Time Held Equity only
7.4 quarters

Top Buys

Rank Stock Value
1
HOLX icon
Hologic
HOLX
+$287M
2
NXPI icon
NXP Semiconductors
NXPI
+$195M
3
NUAN
Nuance Communications, Inc.
NUAN
+$159M
4
ESRX
Express Scripts Holding Company
ESRX
+$138M
5
ARMK icon
Aramark
ARMK
+$133M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$351M
2
FLEX icon
Flex
FLEX
+$215M
3
WBA icon
Walgreens Boots Alliance
WBA
+$214M
4
PNR icon
Pentair
PNR
+$147M
5
ENDP
Endo International plc
ENDP
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 45.86%
2 Industrials 11.12%
3 Materials 10.32%
4 Technology 9.25%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
$817M 5.19%
8,603,438
+1,623,869
+23% +$138M
2018 Q1
2 quarters
FMC icon
2
FMC
FMC
$1.29B
$743M 4.72%
9,831,451
+589,683
+6% +$44.4M
2015 Q1
14 quarters
AET
3
DELISTED
Aetna Inc
AET
$732M 4.65%
3,606,426
+502,104
+16% +$98.1M
2013 Q4
19 quarters
IQV icon
4
IQVIA
IQV
$42.9B
$687M 4.36%
5,296,977
-664,368
-11% -$79.8M
2016 Q2
9 quarters
MCK icon
5
McKesson
MCK
$112B
$646M 4.1%
4,867,591
+157,047
+3% +$20.5M
2016 Q4
7 quarters
DD icon
6
DuPont de Nemours
DD
$17.5B
$645M 4.1%
3,959,958
-600,442
-13% -$103M
2014 Q3
16 quarters
HCA icon
7
HCA Healthcare
HCA
$99.8B
$603M 3.83%
4,335,102
-997,821
-19% -$124M
2013 Q2
21 quarters
TMO icon
8
Thermo Fisher Scientific
TMO
$245B
$539M 3.43%
2,209,942
-336,659
-13% -$77.4M
2013 Q2
21 quarters
FDC
9
DELISTED
First Data Corporation
FDC
$538M 3.42%
22,006,029
-4,689,245
-18% -$113M
2016 Q2
9 quarters
SHPG
10
DELISTED
Shire pic
SHPG
$531M 3.38%
2,931,981
-2,029,918
-41% -$351M
2017 Q1
6 quarters
CVS icon
11
CVS Health
CVS
$112B
$521M 3.31%
6,614,954
+1,192,714
+22% +$85.3M
2017 Q3
4 quarters
THC icon
12
Tenet Healthcare
THC
$21.5B
$509M 3.23%
17,895,314
– –
2013 Q2
21 quarters
DXC icon
13
DXC Technology
DXC
$2.04B
$447M 2.84%
4,784,984
-497,347
-9% -$44M
2017 Q2
5 quarters
NWL icon
14
Newell Brands
NWL
$2.38B
$394M 2.5%
19,392,348
-604,523
-3% -$14.2M
2017 Q4
3 quarters
EBAY icon
15
eBay
EBAY
$51.8B
$382M 2.43%
11,577,436
-361,252
-3% -$12.5M
2016 Q4
7 quarters
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.33T
$378M 2.4%
6,264,820
-337,200
-5% -$20.4M
2015 Q4
11 quarters
ARMK icon
17
Aramark
ARMK
$14.4B
$359M 2.28%
11,567,078
+4,563,501
+65% +$133M
2017 Q4
3 quarters
UHS icon
18
Universal Health Services
UHS
$10.6B
$357M 2.27%
2,791,568
-131,525
-4% -$16.1M
2016 Q3
8 quarters
ELV icon
19
Elevance Health
ELV
$92.2B
$353M 2.24%
1,286,949
+11,287
+0.9% +$2.93M
2014 Q1
18 quarters
HOLX icon
20
DELISTED
Hologic
HOLX
$342M 2.17%
8,335,108
+7,105,488
+578% +$287M
2018 Q2
1 quarter
FDX icon
21
FedEx
FDX
$68.8B
$340M 2.16%
1,410,421
+236,995
+20% +$57.4M
2017 Q3
4 quarters
AGN
22
DELISTED
Allergan plc
AGN
$317M 2.01%
1,663,804
-108,677
-6% -$20M
2017 Q4
3 quarters
WBA icon
23
DELISTED
Walgreens Boots Alliance
WBA
$283M 1.79%
3,875,231
-3,147,738
-45% -$214M
2017 Q2
5 quarters
PARA icon
24
DELISTED
Paramount Global Class B
PARA
$245M 1.56%
4,264,912
-498,375
-10% -$27.5M
2013 Q2
21 quarters
WMB icon
25
Williams Companies
WMB
$91.2B
$233M 1.48%
8,558,315
-1,090,270
-11% -$31.6M
2016 Q2
9 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Glenview Capital Management held 59 positions worth $15.7B, up 7.4% from $14.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Glenview Capital Management's Q3 2018 filing shows 9 new, 17 increased, 27 reduced and 1 closed positions. Its largest new stake was NXP Semiconductors: 2,035,855 shares worth $174M. The largest sale was Shire pic, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 46% a quarter earlier, followed by Industrials and Materials.

  • Glenview Capital Management's largest Q3 2018 buy was NXP Semiconductors: 2,035,855 shares worth $174M.
  • Glenview Capital Management added most to Hologic in Q3 2018, an estimated $287M increase.
  • Glenview Capital Management's biggest Q3 2018 reduction was Shire pic, cutting an estimated $351M.
  • Glenview Capital Management fully exited Pentair in Q3 2018, selling an estimated $147M.
  • Glenview Capital Management's ten largest holdings make up 41% of its $15.7B portfolio in Q3 2018.
  • Glenview Capital Management opened 9 new positions and closed 1 in Q3 2018.
  • Glenview Capital Management's portfolio value rose 7.4% quarter-over-quarter to $15.7B.

Based on Glenview Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.